JPMorgan Chase & Co. Boosts Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

JPMorgan Chase & Co. boosted its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 266.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,714 shares of the company's stock after buying an additional 62,319 shares during the quarter. JPMorgan Chase & Co.'s holdings in Aveanna Healthcare were worth $446,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of AVAH. Creative Planning lifted its holdings in Aveanna Healthcare by 21.3% during the 3rd quarter. Creative Planning now owns 48,502 shares of the company's stock worth $252,000 after buying an additional 8,502 shares during the last quarter. State Street Corp boosted its holdings in Aveanna Healthcare by 0.9% in the third quarter. State Street Corp now owns 1,039,920 shares of the company's stock valued at $5,408,000 after purchasing an additional 9,446 shares in the last quarter. Mackenzie Financial Corp increased its stake in Aveanna Healthcare by 35.9% in the second quarter. Mackenzie Financial Corp now owns 45,674 shares of the company's stock valued at $126,000 after purchasing an additional 12,075 shares during the last quarter. Intech Investment Management LLC acquired a new stake in Aveanna Healthcare during the third quarter worth approximately $69,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Aveanna Healthcare by 3.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company's stock worth $2,406,000 after buying an additional 17,522 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded down $0.20 during trading hours on Friday, reaching $4.60. 221,273 shares of the company traded hands, compared to its average volume of 149,865. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.00 and a 1-year high of $6.19. The stock has a market cap of $888.86 million, a P/E ratio of -13.53 and a beta of 2.25. The firm's 50-day moving average is $4.90 and its 200-day moving average is $4.96.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The firm had revenue of $509.02 million during the quarter, compared to analysts' expectations of $495.80 million. During the same quarter last year, the company posted ($0.05) earnings per share. As a group, research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating for the company in a research note on Monday, January 6th.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.